Sistema complesso per test viremie e screening batteriologico
Original notice title
FORNITURA DI UN SISTEMA COMPLESSO PER TEST IN AUTOMAZIONE PER LE VIREMIE PRINCIPALI (HIV-HBV-HCV-CMV) E SCREENING BATTERIOLOGICO PER MRSA E GBS IN BIOLOGIA MOLECOLARE QUANTITATIVA E QUALITATIVA NECESS
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
50 / 100
Risk factors
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Submission deadline in 1 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 784.8k estimated value
- Supplies contract
- 1 lot
- Duration 1095 DAY
- Supply automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) using quantitative and qualitative molecular biology.
- System to be delivered to Azienda Ospedaliero Universitaria di Ferrara.
Show full summary
Open tender for the supply of an automated system for viremia tests (HIV, HBV, HCV, CMV) and bacteriological screening (MRSA, GBS) for the Microbiology Unit of Azienda Ospedaliero Universitaria di Ferrara. The buyer is Azienda USL di Bologna. Single lot, estimated value €784,790. Submission deadline 16 July 2026. Awarded on most economically advantageous basis (quality). Only notice data available; procurement documents not analyzed.
Risks
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Submission deadline in 1 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Automated system for molecular biology testing.
- System must handle viremia tests (HIV, HBV, HCV, CMV).
- System must handle bacteriological screening (MRSA, GBS).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
AZIENDA USL DI BOLOGNA
Location
Bologna, ITA
Buyer profile
Identifier
02406911202
Lots (1)
LOT-0001
Sistema complesso per test viremie e screening batteriologico
Supply of an automated system for quantitative and qualitative molecular biology testing for HIV, HBV, HCV, CMV viremias and bacteriological screening for MRSA and GBS.
EUR 784.8k
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Sistema complesso per test viremie e screening batteriologico
Procurement Details
- Publication date
- 07 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Italian
Reference metadata
- Notice subtype
- 16
- Notice version
- 3
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 390496-2026
- Source notice ID
- 6a14622e-61df-430c-9631-c85326e82ff7
Documents (2)
Similar tenders
Lithuania – Reagents and contrast media – Reagentai panaudos teise įsigyjamiems analizatoriams
Lithuania – Reagents and contrast media – Reagentai ir priemonės CAR-T kokybės kontrolei I (12124)
Lithuania – Reagents and contrast media – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)
Poland – Reagents and contrast media – Wyroby medyczne do diagnostyki in vitro z dostawą do bezpośrednich odbiorców (zestawy odczynników do oznaczania wiremii HIV-1 RNA). Części 1÷2
Poland – Reagents and contrast media – Wyroby medyczne do diagnostyki in vitro z dostawą do magazynu depozytowego (zestawy odczynników do oznaczania wiremii HIV-1 RNA). Części 1÷3
Poland – Reagents and contrast media – Wyroby medyczne do diagnostyki in vitro z dostawą do bezpośrednich odbiorców (zestawy odczynników do oznaczania poziomu limfocytów CD3/CD4/CD8). Części 1÷3
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
50 / 100
Risk factors
No procurement documents were analyzed; essential details (technical specs, contract terms) are unknown.
Moderate submission timeline (approx. 5 weeks from publication).
Submission deadline in 1 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications